Navigation Links
AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
Date:5/14/2008

turia), difficulty starting urination and/or weak urinary stream, and feeling that the bladder is not completely empty after urination. While current therapies provide some efficacy in BPH they are often associated with troublesome sexual side effects.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization.
News releases and additional information are available at http://www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are requested by a governmental autho
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. AEterna Zentaris to Announce Third Quarter 2007 Financial and Operating Results on November 7, 2007
2. Amarin Announces Private Placement for up to $60 Million
3. NightHawk Radiology Holdings, Inc. Announces Dutch Tender Offer for Its Common Stock
4. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
5. Veria Announces Acquisition of Massage Envy Ltd.
6. TOFUTTI Announces First Quarter Results
7. Natural Alternatives International, Inc. Announces Third Quarter Results
8. eDiets.com(R) Announces Q1 2008 Results
9. Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
10. United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results
11. The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... The Delta Dental Foundation is currently seeking applications ... Ohio and Indiana for its Brighter Futures Community Grants ... been set. , Across the tri-state area, the program ... focus on children’s oral health and $100,000 in grants ... Each grant request will be considered and carefully reviewed ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 On May ... Care center hosted the Cherry Creek Chamber of ... care clinic. Urgent care centers typically do not offer ... allow AFC/Doctors Express Cherry Creek Urgent Care staff to ... physicals. , From 5:30 to 7:30 p.m. the center ...
(Date:6/1/2015)... Cambia Health Solutions and America’s Health ... Affordable Care Act (ACA) training course to engage ... Care Act Expert Series, Large Group Training,” provides ... insights necessary to effectively engage and support large ... the ACA. , The interactive, experience-based course includes:, ...
(Date:6/1/2015)... Note: Dr. Julian is available for interviews today ... A phase III trial funded by the National Institutes ... in situ (DCIS) now have an additional tool for ... B-35/NRG Oncology) looked at more than 3,000 DCIS survivors, ... tamoxifen to those who completed five years of the ...
(Date:6/1/2015)... More than 22 million children may miss ... is out and they lose access to free or reduced-price ... farmers and milk companies are on a mission to bring ... American Milk Drive. , In many cases, food insecure ... cafeteria for the bulk of their daily nutrition. Although the ...
Breaking Medicine News(10 mins):Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2
... Using spices eaten in the Mediterranean diet as natural antioxidants ... the beneficial health effects of these products. This has been ... have put the clove in first place. Researchers from ... ) as the best antioxidant spice, due to the fact ...
... , ... available April 1 , ... N.C. (Vocus) March 16, 2010 -- Prodigy Diabetes Care, LLC, is launching its new Prodigy ... , , , , ,The Prodigy Count-a-dose™ offers diabetics a device which can easily measure ...
... , ... Receive Major Addiction Certifications at No or Low Cost , ... (PRWEB) March 16, 2010 -- During economic times like ... human talent is left by the wayside as a result. For an addict these challenges ...
... Ten years later, many men weren,t bothered by treatment,s ... -- The balance between using enough radiation to ... effects at bay may not be as tricky as ... side effects appear to lessen with time. In fact, ...
... ... Latest Cosmetic Surgery Imaging System for the equivalent cost of a few dermal filler ... Toronto, ... virtual makeover tools, today announced the launch of VuMe, the company’s latest surgical imaging ...
... March 16 On Monday, March 22, 2010 ... will host a "Meet the Author!" webcast entitled "How Healthy Could ... Population Health Sciences and the Emeritus Vice Chancellor for Health Sciences ... Public Health, will discuss how states might expect their mortality rates ...
Cached Medicine News:Health News:Cloves are the best natural antioxidant 2Health News:Prodigy Re-Launches Syringe-Filling System for Blind and Low-Vision Diabetics 2Health News:Academy's Community Initiative Offers Qualifying Former Addicts Free Vocational Training 2Health News:Prostate Cancer Radiation Side Effects May Subside With Time 2Health News:ModiFace Launches VuMe in Southern Florida – the World's First Full-Featured Touch-Screen Cosmetic Surgery Imaging System 2Health News:ModiFace Launches VuMe in Southern Florida – the World's First Full-Featured Touch-Screen Cosmetic Surgery Imaging System 3Health News:Public Health Reports Will Host A 'Meet the Author!' Webcast Entitled 'How Healthy Could a State Be' 2
(Date:6/1/2015)... Middle Eastern MRI systems market is fast growing. MRI being ... of medicine like cardiology, neurology and orthopedics. It is replacing ... is as safer tool as it does not use ionizing ... into Open system, closed system and straight or upright system. ... it is preferred over that currently common closed type as ...
(Date:6/1/2015)... June 1, 2015  Diomics, an innovator in DNA ... , global financial executive, has joined Diomics, board of ... than 25 years of industry experience in broad global ... a managing director at Credit Suisse and JP Morgan, ... Witter. "Diomics is on the forefront of ...
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global Power Wheelchair Industry Report 2014" ... Global Power Wheelchair Industry Report 2014 is a ... of the power wheelchair industry. The ... including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3Richard M. Weissman joins Diomics Board of Directors 2Global Power Wheelchair Industry Trends 2015-2020 2
... The Leukemia & Lymphoma,Society has awarded a $550,000 ... Wilmot Cancer Center at the University of Rochester Medical,Center. ... funding the first two years of the five-year program., ... will support,Dr. Friedberg,s work on a new targeted treatment ...
... Assay Submitted for FDA Clearance, SAN DIEGO, July ... and Company) (NYSE: BDX ), announced today the ... the rapid diagnosis,of patients with Clostridium difficile infection (CDI). ... simplicity and speed in one test,procedure. BD has also ...
Cached Medicine Technology:University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
ESR-Vacuum Tubes are evacuated tubes used for the collection of venous blood. ESR-Vacuum Tubes are used to transport and process blood for testing the Erythrocyte Sedimentation Rate (ESR) of whole bl...
Medicine Products: